Literature DB >> 1972853

Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system.

K Wakabayashi1, H Takahashi, E Ohama, F Ikuta.   

Abstract

We performed immunohistochemical analysis of specimens from three autopsied patients with Parkinson's disease, using antibodies to tyrosine hydroxylase (TH), vasoactive intestinal polypeptide (VIP), somatostatin, met-enkephalin, leu-enkephalin and substance P in an attempt to reveal the types of neurons that contain Lewy bodies (LBs) in the paravertebral and celiac sympathetic ganglia and in the enteric nervous system of the alimentary tract. In the sympathetic ganglia, almost all LB-containing neuronal cell bodies and processes were immunoreactive for TH. In the alimentary tract, however, most LBs were found in the VIP-immunoreactive (VIP-IR) neuronal cell bodies and processes. In spite of the significant presence of TH-IR neuronal cell bodies and processes in the alimentary tract, LB-containing TH-IR neuronal elements were rarely encountered. These findings indicate that in the alimentary tract, the VIP neuron system is mainly involved in the disease process of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972853     DOI: 10.1007/bf00294234

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  16 in total

1.  ALIMENTARY DISORDER IN PARKINSONISM.

Authors:  M J EADIE; J H TYRER
Journal:  Australas Ann Med       Date:  1965-02

2.  Editorial: Dysphagia in parkinsonism.

Authors:  J A Logemann; E R Blonsky; B Boshes
Journal:  JAMA       Date:  1975-01-06       Impact factor: 56.272

3.  Megacolon and dilatation of the small bowel in parkinsonism.

Authors:  A LEWITAN; L NATHANSON; W R SLADE
Journal:  Gastroenterology       Date:  1951-03       Impact factor: 22.682

4.  Oesophageal dilatation in Parkinson's disease.

Authors:  F B Gibberd; J A Gleeson; A A Gossage; R S Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-08       Impact factor: 10.154

5.  Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.

Authors:  S J Qualman; H M Haupt; P Yang; S R Hamilton
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

6.  Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses.

Authors:  K Wakabayashi; H Takahashi; S Takeda; E Ohama; F Ikuta
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

7.  Regulatory peptides in the lower esophageal sphincter of man.

Authors:  S Aggestrup; R Uddman; S L Jensen; F Sundler; O Schaffalitzky de Muckadell; J J Holst; R Håkanson; R Ekman; H R Sørensen
Journal:  Regul Pept       Date:  1985-03

Review 8.  Lewy bodies in the enteric nervous system in Parkinson's disease.

Authors:  K Wakabayashi; H Takahashi; S Takeda; E Ohama; F Ikuta
Journal:  Arch Histol Cytol       Date:  1989

9.  Enteric nerves in diabetic rats: electron microscopic evidence for neuropathy of vasoactive intestinal polypeptide-containing fibres.

Authors:  A Loesch; A Belai; J Lincoln; G Burnstock
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia.

Authors:  S Aggestrup; R Uddman; F Sundler; J Fahrenkrug; R Håkanson; H R Sørensen; G Hambraeus
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

View more
  92 in total

1.  Homeodomain interacting protein kinase 2 regulates postnatal development of enteric dopaminergic neurons and glia via BMP signaling.

Authors:  Alcmène Chalazonitis; Amy A Tang; Yulei Shang; Tuan D Pham; Ivy Hsieh; Wanda Setlik; Michael D Gershon; Eric J Huang
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

2.  Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.

Authors:  Brittany N Dugger; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2010-08-19       Impact factor: 17.088

3.  Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.

Authors:  L Wang; I Magen; P-Q Yuan; S R Subramaniam; F Richter; M-F Chesselet; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-11       Impact factor: 3.598

Review 4.  Innervation of the gastrointestinal tract: patterns of aging.

Authors:  Robert J Phillips; Terry L Powley
Journal:  Auton Neurosci       Date:  2007-05-29       Impact factor: 3.145

5.  Ca2+/calmodulin-dependent protein kinase II immunoreactivity in Lewy bodies.

Authors:  T Iwatsubo; I Nakano; K Fukunaga; E Miyamoto
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?

Authors:  R J Phillips; G C Walter; S L Wilder; E A Baronowsky; T L Powley
Journal:  Neuroscience       Date:  2008-03-18       Impact factor: 3.590

7.  Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat.

Authors:  Robert J Phillips; Gary C Walter; Brittany E Ringer; Katherine M Higgs; Terry L Powley
Journal:  Exp Neurol       Date:  2009-08-05       Impact factor: 5.330

8.  Autonomic dysfunction and plasticity in micturition reflexes in human α-synuclein mice.

Authors:  Robert W Hamill; John D Tompkins; Beatrice M Girard; Richard T Kershen; Rodney L Parsons; Margaret A Vizzard
Journal:  Dev Neurobiol       Date:  2012-06       Impact factor: 3.964

Review 9.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

10.  Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease.

Authors:  Shinji Ito; Masaki Takao; Hiroyuki Hatsuta; Kazutomi Kanemaru; Tomio Arai; Yuko Saito; Masashi Fukayama; Shigeo Murayama
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.